POLRMT and hematologic disorder: So far, it was proven to be overexpressed in hematological malignancies, and knockdown of POLRMT expression significantly inhibited the growth of leukemia cells, mitochondrial complex I activity, and oxidative phosphorylation without affecting the cell cycle [29].